Prevalence of Potential and Clinically Relevant Statin-Drug Interactions in Frail and Robust Older Inpatients. (Q40459838)

20 September 2017

title

Prevalence of Potential and Clinically Relevant Statin-Drug Interactions in Frail and Robust Older Inpatients. (English)

1 reference

20 September 2017

Emily Reeve

4

0 references

Danijela Gnjidic

series ordinal

5

object named as

Danijela Gnjidic

1 reference

20 September 2017

3

Sallie-Anne Pearson

1 reference

20 September 2017

2

Sarah Hilmer

1 reference

20 September 2017

Michele Thai

1

1 reference

20 September 2017

publication date

6 October 2015

1 reference

20 September 2017

1 reference

20 September 2017

volume

32

1 reference

20 September 2017

issue

10

1 reference

20 September 2017

page(s)

849-856

1 reference

Potentially harmful drug-drug interactions in the elderly: a review

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0302-9

Hospitalisations and emergency department visits due to drug-drug interactions: a literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0302-9

Clinical implications from drug-drug and drug-disease interactions in older people

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0302-9

Clinical pharmacology in the geriatric patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0302-9

Prevalence and impact of fall-risk-increasing drugs, polypharmacy, and drug-drug interactions in robust versus frail hospitalised falls patients: a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0302-9

High-risk prescribing and incidence of frailty among older community-dwelling men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0302-9

Identification of serious drug-drug interactions: results of the partnership to prevent drug-drug interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0302-9

Comparison of critical drug-drug interaction listings: the Department of Veterans Affairs medical system and standard reference compendia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0302-9

Comparative assessment of four drug interaction compendia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0302-9

Statin use and clinical outcomes in older men: a prospective population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0302-9

Statins for secondary prevention in elderly patients: a hierarchical bayesian meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0302-9

Efficacy and safety of statin monotherapy in older adults: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0302-9

Pharmacological interactions of statins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0302-9

Statin drug interactions and related adverse reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0302-9

Statin safety and drug interactions: clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0302-9

Drug interactions with lipid-lowering drugs: mechanisms and clinical relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0302-9

Statin toxicity from macrolide antibiotic coprescription: a population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0302-9

Concomitant use of statins and CYP3A4 inhibitors in administrative claims and electronic medical records databases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0302-9

Statin-macrolide interaction risk: a population-based study throughout a general practice database.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0302-9

Prevalence of potentially hazardous drug interactions amongst Australian veterans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0302-9

The assessment of frailty in older people in acute care.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0302-9

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0302-9

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0302-9

An examination of the effect of cytochrome P450 drug interactions of hydroxymethylglutaryl-coenzyme A reductase inhibitors on health care utilization: a Canadian population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0302-9

The prevalence of co-prescription of clinically relevant CYP enzyme inhibitor and substrate drugs in community-dwelling elderly Australians.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0302-9

Detection and prevention of drug-drug interactions in the hospitalized elderly: utility of new cytochrome p450-based software

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0302-9

Investigating polypharmacy and drug burden index in hospitalised older people.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40266-015-0302-9

The relationship between number of drugs and potential drug-drug interactions in the elderly: a study of over 600,000 elderly patients from the Swedish Prescribed Drug Register

21 January 2018

1 reference

12 December 2020

Safety of statins: focus on clinical pharmacokinetics and drug interactions

1 reference

12 December 2020

The association of age and frailty with paracetamol conjugation in man

1 reference

12 December 2020

Concordance of severity ratings provided in four drug interaction compendia

1 reference

12 December 2020

A national census of medicines use: a 24-hour snapshot of Australians aged 50 years and older

1 reference

12 December 2020

Co-administration of statins with cytochrome P450 3A4 inhibitors in a UK primary care population

1 reference

12 December 2020

Prevalence and risk of potential cytochrome P450-mediated drug-drug interactions in older hospitalized patients with polypharmacy

1 reference

12 December 2020

Quality of drug interaction alerts in prescribing and dispensing software

1 reference

12 December 2020

Results of a Safety Initiative for Patients on Concomitant Amiodarone and Simvastatin Therapy in a Veterans Affairs Medical Center

1 reference

12 December 2020

Frequency of simvastatin prescriptions with potentially interacting medications in a Veterans Affairs health care system

1 reference

12 December 2020

Risk factors for rhabdomyolysis with simvastatin and atorvastatin

1 reference

12 December 2020

1 reference

12 December 2020

The impact of frailty on pharmacokinetics in older people: using gentamicin population pharmacokinetic modeling to investigate changes in renal drug clearance by glomerular filtration

1 reference

12 December 2020

10.1007/S40266-015-0302-9

Identifiers

DOI

1 reference

Dimensions Publication ID

20 September 2017

1026846921

0 references

1 reference